Heron Therapeutics Inc (HRTX) has fallen 4.93% Monday In Premarket Trading

Heron Therapeutics Inc (HRTX) has fallen Monday morning, with the stock decreasing -4.93% in pre-market trading to 4.44. HRTX's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 118 out of 146 industries, the stock ranks higher than 56% of stocks. Heron Therapeutics Inc has fallen 2.51% over the past month, closing at $4.44 on August 22. During this period of time, the stock fell as low as $3.92 and as high as $5.14. HRTX has an average analyst recommendation of Strong Buy. The company has an average price target of $10.10.

HRTX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on HRTX!

See Full HRTX Report

Heron Therapeutics Inc has a Long-Term Technical rank of 88. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 12% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, HRTX ranks better than 47% of stocks.

Important Dates for Investors in HRTX:

-Heron Therapeutics Inc is set to release earnings on 11/2/2022. Over the last 12 months, the company has reported EPS of $-2.22. -We do not have a set dividend date for Heron Therapeutics Inc at this time. Click Here To Get The Full Report on Heron Therapeutics Inc (HRTX)